Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Melatonin receptor ligands described by ADIR

Nov. 26, 1996

New NMDA antagonists described by Zeneca

Nov. 26, 1996

Three additional approvals for Rilutek

Nov. 25, 1996

Marinol promising for geriatric AD

Nov. 25, 1996

SNX-111 effective in chronic intractable pain

Nov. 25, 1996

Maxi-K channel modulators from Bristol-Myers Squibb

Nov. 25, 1996

Lilly claims structurally novel NK1 antagonists

Nov. 25, 1996

NeoTherapeutics' lead small molecule advances toward clinical trials in AD

Nov. 22, 1996

Guilford's orally active neuroimmunophilin highly effective in animal models of Parkinson's disease

Nov. 22, 1996

Lamotrigine now available in France

Nov. 22, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...